Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Indraprastha Medical Corporation Ltd (IMCL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
266.55 +20.95    +8.53%
10:59:58 - Closed. Currency in INR ( Disclaimer )
  • Volume: 84,575
  • Bid/Ask: 263.55 / 266.55
  • Day's Range: 248.25 - 278.55
Type:  Equity
Market:  India
ISIN:  INE681B01017 
S/N:  INDRAMEDCO
Indraprastha Medical 266.55 +20.95 +8.53%

NS:IMCL Financials

 
This summary provides an overview of the most significant critical numbers from each of the Indraprastha Medical Corporation Ltd financial reports, including theIndraprastha Medical Corporation Ltd income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NS:IMCL financials over time via breakdowns of their annual reports.

Indraprastha Medical Corporation Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 3,147.3 million compared to INR 2,740.5 million a year ago. Revenue was INR 3,196.2 million compared to INR 2,788.4 million a year ago. Net income was INR 311.7 million compared to INR 198.4 million a year ago. Basic earnings per share from continuing operations was INR 3.4 compared to INR 2.16 a year ago. Diluted earnings per share from continuing operations was INR 3.4 compared to INR 2.16 a year ago.For the full year, sales was INR 12,447 million compared to INR 10,986.7 million a year ago. Revenue was INR 12,615.9 million compared to INR 11,087 million a year ago. Net income was INR 1,239.6 million compared to INR 861.5 million a year ago. Basic earnings per share from continuing operations was INR 13.52 compared to INR 9.4 a year ago. Diluted earnings per share from continuing operations was INR 13.52 compared to INR 9.4 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

IMCL Income Statement & Profits

Gross margin TTM 57.24%
Operating margin TTM 11.56%
Net Profit margin TTM 9.35%
Return on Investment TTM 25.77%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 3064.6 3170 3065.1 2732.7
Gross Profit 1124.5 1152.6 1120.3 3494.8
Operating Income 372.7 403.3 374.5 233.7
Net Income 294.4 328.5 305 198.4

IMCL Balance Sheet

Quick Ratio MRQ 1.33
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1.13%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 6675.6 5551.4
Total Liabilities 2528.1 1756.9
Total Equity 4147.5 4147.5 3794.5 3794.5

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 11.82
Revenue/Share TTM 131.34
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IMCL Price Commentary

Write your thoughts about Indraprastha Medical Corporation Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bappa Das
Bappa Das May 04, 2024 16:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's a gem
Bappa Das
Bappa Das May 04, 2024 16:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's a gem
Ajit Pal
Ajit Pal Jul 07, 2021 6:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I had buy at 102, what should I hold or sold indraprastha medical
Ajit Pal
Ajit Pal Jul 07, 2021 6:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I had buy at 102, what should I do hold or sold
Ajit Pal
Ajit Pal Jul 07, 2021 6:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I had buy at 102, what should I do hold or sold
Sachin Goel
Sachin Goel Nov 19, 2019 8:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy 45.3 to 45.6 target 52 best 2 days without stop lose
Vikash kumar
Vikash kumar Feb 08, 2018 14:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email